Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.
Mar 11, 2021
0
4
Research has found fidaxomicin, an antibiotic usually used to treat bowel infections, prevents growth of resistant strains of Mycobacterium tuberculosis (MTb) in the lab.
Feb 17, 2021
0
3
Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time—and ...
Feb 3, 2021
0
59
Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust. In an effort to ...
Jan 6, 2021
1
95
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania ...
Aug 10, 2020
0
2
A new study led by scientists at the University of Birmingham has shed fresh light on how a key front-line drug kills the tuberculosis bacterium.
Apr 23, 2020
0
110
Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E. Today, the World Health Organization ...
Feb 24, 2020
1
68
A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...
Dec 17, 2019
0
54
A team of researchers at the Indian Institute of Science and the Tata Institute of Fundamental Research, both in India, have found that the antimalarial drug chloroquine can make the tuberculosis bacteria more sensitive to ...
A pharmaceutical multinational on Thursday slashed the price of a key anti-tuberculosis drug boosting the battle against the world's deadliest infectious disease, as a new treatment was also set to begin extensive testing.
Oct 31, 2019
0
52
